Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy

Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of Bcr–Abl, a constitutively active tyrosine kinase [1]. Inhibition of Bcr–Abl with tyrosine kinase inhi...